Viagra drug to be made available over counter for first time
VIAGRA CONNECT – a newly branded name for the famous medicine for adult men suffering from impotence – can be bought over the counter for the first time in the coming weeks.
Viatris announced the launch yesterday of the medicine to be known as Viagra Connect as a nonprescription, pharmacysupplied treatment for adult men with erectile dysfunction. Sildenafil, commonly known by its brand name Viagra, was the first oral drug for erectile dysfunction to hit the market in 1998 and has been prescribed for more than 64 million men worldwide.
A spokeswoman said the hope was that the availability of Viagra Connect in Irish pharmacies would encourage men to get help for the condition. It should facilitate early diagnosis and the management of both erectile dysfunction and any underlying cardiovascular conditions.
She said Viatris had implemented an extensive training and education programme with pharmacists to ensure Viagra Connect was supplied in a way that supports patient safety.
“In order to purchase the product, men will need to answer some questions about their health so that the pharmacist can determine whether Viagra Connect is suitable for them.”
Erectile dysfunction (ED) is defined as the inability to achieve or maintain an erection firm enough for sex.
It is regarded as a common condition and can affect men as they get older.
It can happen occasionally or frequently varying in severity from mild to severe.
David Delaney, director of Europe Policy and Market Access at Viatris said: “As a leader in men’s health, Viatris is pleased to provide men a safe and convenient way to treat their erectile dysfunction.
“Our hope is that the availability of Viagra Connect in pharmacies will encourage men to seek help, and thereby facilitate early diagnosis and management of both ED and underlying co-morbid cardiovascular conditions.
“Pharmacists should advise men to follow up with their doctor at their earliest convenience within six months of being supplied the product, so that any potential underlying conditions or risk factors associated with erectile dysfunction can be investigated.”
This reclassification will not apply to the original medicine under its brand name Viagra which remains subject to prescription.